That's essential, since the method a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work. Simply put, we need to know how these proteins fold if we desire a drug to work. Historically, this has been a trial-and-error process (jeff brown biotech genome sequencing). Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to develop drugs that do what they're created to do. This was a breakthrough nearly no one noticed. But it's going to have extensive implications for curing disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be plenty of investment opportunities in this space, too. Moving subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it pulled back perhaps substantially before going greater - melania trump. I have actually been covering bitcoin for a very long time now. One of the first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were mainly educating readers. However that's not the big concern any longer. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. self-driving cars. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are many great private companies on the edge of hitting the public markets And I have actually been dealing with a new way for you to invest even prior to these companies go public.
This chance has been developing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the details. Go right here to book your area free of charge.
Emma Walsh here, managing editor of the Diary. Routine Diary readers know that tech isn't our typical beat (united arab emirates). And when it comes to tech investing, we leave it to the specialists. Thankfully, we have numerous such experts in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing professionals we know (angel investor). In reality, he had several triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge picture and forecast what's just around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and far more. These trends are experiencing rapid growth and producing amazing opportunities for investors. I want to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. future report review. However despite what numerous readers might think, this is a pattern that's simply starting. Even though the COVID-19 pandemic interrupted supply chains last year, a remarkable 250 million 5G-enabled gadgets were still offered.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by two months (united arab emirates). Losing two months of manufacturing and sales really affects the number of 5G gadgets are sold in the calendar year. When you consider all of that, selling 250 million units is remarkable. More notably, the hold-ups triggered by the pandemic developed a lots of bottled-up need. Which need is now going to be pressed into 2021. In fact, I forecast that more than 500 million 5G gadgets will be delivered in 2021 - jeff brown stock market prediction. And that's not my only 5G forecast When I've spoken about 5G in the past, I've explained its three various stages.
In Phase Two, 5G devices go on sale. 5G phones and other products start to reach customers. And in Phase Three, 5G services begin to be used (biotech stock). That's when we start to see applications working on 5G networks. Consider things like massive multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Stage 3 by this summer season. This begins something of a virtuous cycle: The majority of individuals do not actually care about the innovation. However they will care if there are amazing applications that can just be accessed with a 5G phone.
That leads to more 5G apps being established. In fact, 5G is going to open a suite of amazing applications: self-driving vehicles, the Internet of Things, robotic surgery, and more. All of these technologies need 5G. The financial investment opportunities going forward will be massive. Stepping away from 5G, the next essential technology I visualize in 2021 is CRISPR genetic editing. CRISPR represents "clustered frequently interspaced brief palindromic repeat." It's a mouthful. But it is among the most exciting advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software application.
The program can crash or not work properly. CRISPR uses a comparable concept however with our genetic code. "Typos" in our genome can result in illness. CRISPR can remedy these "typos." For many years, CRISPR was mainly a specific niche technology that wasn't well understood. And during that time, there were truly only three companies running in this space. But things are changing. CRISPR is no longer simply theoretical. We're seeing real results. We're treating diseases and seeing that this innovation just works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and providing unbelievable returns. This whole industry is successfully a greenfield chance.
There's room for numerous business to exist in this space. jeff brown biotech picks. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or three more hereditary modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing amazing things taking place at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software can precisely forecast the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That is essential since the method a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been an experimental process. Today, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to develop drugs that do what they're designed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however numerous drug therapies produced using this innovation. This was among those developments that nearly nobody observed. However it's going to have extensive ramifications for curing illness. And, obviously, there will be a lot of investment chances in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be shocked if it drew back perhaps substantially before going higher. I have actually been covering bitcoin for a long period of time now. Among the first research reports I ever released was on bitcoin - social media. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my recommendation. But at the time of that initial recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that concern anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. united states. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the details is up to date as of February 2021, however we might not separately validate this claim. Offered Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an exact figure at this minute. Brown is best known for his sage-like ability to select winning technology stocks. He spent more than 25 years looking into technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an exceptional point of view on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares much of his finest picks in the Near Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an excellent track record as a stock-picker, and he effectively anticipated a few of the biggest economic events of the previous 20 years. Although he does not appear to launch his picks to the public, the service's success is a direct indicator of Brown's stock-picking prowess. Nobody on Wall Street gets it right every time, but Jeff Brown's precise forecasts have made him legions of devoted fans. That states a lot about his ability. The Future Report is published by Brownstone Research study, a prominent monetary research publisher. Brownstone Research offers several research services with a wide range of expertises - biotech stocks.
The company is also connected with Bonner & Partners, another well-respected research study publisher - jeff brown genome sequencing stock. On its website, Brownstone says its mission is to supply retail investors with professional-grade research: "For too long, the finest financial investment research study has not been readily available to individual financiers. It has been generally reserved for investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown genome sequencing stock. The mission of Brownstone Research is to make that sort of proprietary research available to any financiers seeking to acquire an edge in the marketplaces. The goal is simple to deliver unique and profitable investment research study discovered nowhere else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research, and he also serves as the firm's Chief Investment Expert.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to offer its customers. After decades of consistent success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a family name throughout the majority of America. If you understand even a bit about the market, you understand that he has a reputation as a King Midas of sorts. jeff brown genetic sequencer stock. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In truth, Brown believes S.A.V. legacy report prediction. might be "the greatest pattern of the 2020s, and he's not alone. Have a look at these quotes from other well-known S.A.V. bulls: Elon's next huge act will be marrying 2 cutting-edge innovations: expert system and electric vehicles. Musk hopes the mix will assist him develop the very first fully-autonomous, self-driving cars ever. It's nothing short of the automotive market's Holy Grail. As you understand, electric automobiles and self-driving cars and truck stocks have been huge this year, however the Wall Street device has approved hype without much tangible result. Despite an extreme increase in competition over the previous couple of years, Brown still believes Musk has the best opportunity of putting everything together.
tech could be the magic string that connects everything together. S.A.V. stands for Shared Autonomous Automobile, and it could be the future of transport. Essentially, this technology would permit you to rent your automobile as an autonomous, self-driving taxi when you're not utilizing it. You simply get out of the cars and truck and press a button on an app that tells the car to "join the fleet." Next thing you know, you're unwinding on your sofa while your car shuttles ride-sharers around town. Most importantly, you get to keep a hefty piece of the revenues. It sounds insane, however it could be closed than you believe.